Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CHDX--US China Industrial Exchange -- Ignore unavailable to you. Want to Upgrade?

To: Barry Shore who wrote (38)	4/25/1998 12:34:00 PM
From: WWS	Respond to of 77

Barry, I don't own enough CHDX to justify attending annual shareholders meeting, but maybe someone else here will. You noted that CHDX shifted focus from "bricks and mortar" to "birth and health". But when I reread the initial news release about the PLC systems distribution agreement w/CHDX I found statement by CHDX that they've been involved distributing cardiovascular health-related products for "15" years, and PLC's president stating that CHDX was "leading health products distributor" in China. Message 3473281 BTW, I don't think that there will be an immediate effect next week on CHDX's stock price due to FDA recommendation of approval of PLC's TMR laser. Very few outside of this thread (and perhaps the PLC thread) are actively aware of the connection between us and them. But it will be good for the long term, as I imagine that we'll see a significant upswing in PR for PLC systems lasers, as witness the following news release, also from this weekend's news: healthgate.com Eventually, the medical benefits of the procedure will translate into increased sales for PLC TMR lasers, both here and in China. Always good to hear from you, too. Bill

To: Barry Shore who wrote (38)	5/10/1998 5:26:00 PM
From: Bill Bishop	Read Replies (1) \| Respond to of 77

More Good News? Healthcare Demands Drive China's Medical Market, But U.S. Sales Lag Behind Europe SAN DIEGO, May 8 /PRNewswire/ -- Sales of medical products in China are expected to be robust in 1998 despite a regional slowdown brought on by the 1997 currency crisis. Demand for better healthcare is driving the medical market which is predicted to grow by 20% during the next three years according to a report released by San Diego-based Golden Triangle Organization. The report, ''1998 China Medical Market Report: An In-depth View of China's Pharmaceutical, Medical Device & Biotechnology Industries,'' found however, that U.S. medical equipment exporters are losing market share to European and Israeli companies offering attractive financing terms to Chinese hospitals. ''In 1997, U.S. sales of medical equipment in China was $121 million -- essentially unchanged from the previous year,'' said Deborah D. Miller, GTO's president. ''Exports from Finland, Norway, Germany and Israel increased at double-digit levels from 1996-1997,'' she added. Attractive financing options no doubt impacted sales revenues of companies selling into China as access to capital remains one of the country's main challenges. Urban healthcare is in the process of being privatized and the Chinese government has shifted its focus to improving the healthcare needs of over 880 million rural Chinese. Chinese hospitals now face a severe funding shortage and are turning to exporters not only for equipment but financing. ''Offering financing options, whether from private sources or government- assisted loans, gives these companies a definite advantage when selling into China,'' said Miller. According to Miller, the U.S, Export-Import Bank is working in conjunction with the U.S. Department of Commerce to educate commercial attaches and U.S. companies on Ex-Im Bank programs including tied-aid loan programs. The Ex-Im Bank first participated in a tied-aid loan program in 1996 when it granted a U.S. medical equipment distributor, U.S.-Chindex, an $8.4 million low-rate loan package to export medical equipment to China. On a brighter note, U.S. exporters of laboratory equipment remain the leaders according to the 1998 China Medical Market Report. ''Chinese researchers universally prefer U.S. laboratory instruments, analyzers and reagents,'' said Miller who noted that their preference is based on high- quality and ease-of-use. Miller added that biotechnology is being targeted by the government as an emerging industrial sector which will continue to drive demand for this type of equipment.